# FDA Inspection 1201856 - Samsung Biologics Co., Ltd. - February 28, 2023

Source: https://www.keypedia.com/records/fda_inspections/samsung-biologics-co-ltd/769da2e8-0f45-4a78-ae4e-7e9cefc4d32f
Source feed: FDA_Inspections

> FDA Inspection 1201856 for Samsung Biologics Co., Ltd. on February 28, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201856
- Company Name: Samsung Biologics Co., Ltd.
- Inspection Date: 2023-02-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1269570 - 2025-05-27](https://www.keypedia.com/records/fda_inspections/samsung-biologics-co-ltd/d20015df-a132-4e1e-be47-84e8a2b9ad6f)
- [FDA Inspection 1218067 - 2023-09-01](https://www.keypedia.com/records/fda_inspections/samsung-biologics-co-ltd/4f09b686-db97-4bd1-85fb-2ebcd9a54f72)
- [FDA Inspection 1108244 - 2019-11-01](https://www.keypedia.com/records/fda_inspections/samsung-biologics-co-ltd/7097d01b-422a-4c04-aabf-43ae536c0e32)
- [FDA Inspection 1056899 - 2018-06-26](https://www.keypedia.com/records/fda_inspections/samsung-biologics-co-ltd/3f506971-1c3a-4a46-87c6-4997cb368f5a)

Company: https://www.keypedia.com/companies/samsung-biologics-co-ltd/817b7bc4-2de1-47f4-b552-178303c8da01

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d